Loading...

Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision

The hormone dependent breast and prostate cancers have in general a very good survival, due to the anti-hormonal treatment. A disadvantage of this treatment is the increased risk of osteoporosis and fractures. It is surprisingly to note that denosumab has the same impact on fracture reduction incide...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Facts Views Vis Obgyn
Hovedforfatter: Tjalma, W.A.A.
Format: Artigo
Sprog:Inglês
Udgivet: Universa Press 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788334/
https://ncbi.nlm.nih.gov/pubmed/26977268
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!